ClosedUnited KingdomGoods£15,169,777
Transitional Drugs 3
- Published
- Published 19 December 2024
- Deadline
- Closed 23 January 2025
Overview
Drugs which have recently lost their patent exclusivity
Key details
- Country
- United Kingdom
- Status
- Closed
- Category
- Goods
- Estimated value
- £15,169,777
- Procedure
- Open
- Published
- 19 December 2024
- Deadline
- Closed
Pharmaceutical products
Award outcome
- Awarded value
- £29,045,630
- Award date
- 14 April 2025
- Contract period
- 31 March 2025 → 30 June 2026
- Amgen Ltd
- Biogen Idec Ltd
- Celix Pharma
- Celltrion Healthcare Uk Ltd
- Fresenius Kabi Ltd
- Roche Products Ltd
- Sandoz Ltd
- Sun Pharma Ltd
- Thornton & Ross Ltd
- Tillomed Laboratories Ltd
- Zentiva Ltd
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract
14 May 2025
View notice ↗Contract Notice
19 December 2024
View notice ↗
Contracting authority
Velindre NHS Trust
BuyerNewport, United Kingdom
Authority website ↗Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales UHBs & Trusts
BuyerNewport, United Kingdom
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.